Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

MMOONLAKE IMMUNOTHERAPEUTICS

EconomyAI buildoutMarket MapFundsWatchlist
Log in
M

MOONLAKE IMMUNOTHERAPEUTICS

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Jul 27, 2026Reich KristianChief Scientific Officer1,100Class A ordinary shares, par value $0.0001 per share—Sell
Jul 22, 2026Reich KristianChief Scientific Officer2,448Class A ordinary shares, par value $0.0001 per share—Sell
Jul 21, 2026Reich KristianChief Scientific Officer50,000Class A ordinary shares, par value $0.0001 per share—Sell
Jul 20, 2026Reich KristianChief Scientific Officer43,700Class A ordinary shares, par value $0.0001 per share—Sell
Jul 15, 2026Reich KristianChief Scientific Officer16,105Class A ordinary shares, par value $0.0001 per share—Sell
Jul 10, 2026Santos da Silva JorgeChief Executive Officer68,289Class A ordinary shares, par value $0.0001 per share—Sell
Jul 9, 2026Santos da Silva JorgeChief Executive Officer33,936Class A ordinary shares, par value $0.0001 per share—Sell
Jul 1, 2026Santos da Silva JorgeChief Executive Officer47,775Class A ordinary shares, par value $0.0001 per share—Sell
Jun 22, 2026Bodenstedt MatthiasChief Financial Officer39,120Class A ordinary shares, par value $0.0001 per share—Sell
Jun 18, 2026Bodenstedt MatthiasChief Financial Officer2,794Class A ordinary shares, par value $0.0001 per share—Sell
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions